首页> 外文会议>Annual meeting exposition of the Controlled Release Society >Optimization of fabrication parameters to produce chitosan-TripolyphosphateNanoparticles for P53 gene delivery
【24h】

Optimization of fabrication parameters to produce chitosan-TripolyphosphateNanoparticles for P53 gene delivery

机译:优化生产参数以生产用于P53基因递送的壳聚糖-三聚磷酸盐纳米颗粒

获取原文

摘要

Safe, efficient, and specific delivery oftherapeutic genes remains an importantbottleneck for the development of genetherapy. Novel biocompatible polymeric genecarriers have been examined for their potentialin treating various genetic and acquireddiseases. Inefficient endosomal release,cytoplasmic transport, and nuclear entry ofplasmids are currently limiting factors in theuse of polymers for effective plasmid- basedgene therapy [1]. Therefore, several differentpolymeric gene carriers have been designedrecently in an attempt to overcome theseproblems. Biocompatibility, lowimmunogenicity and minimal Cytotoxicity canrender such polymers a good alternative toviral or lipid mediated transfection. Chitosan isa cheap, biocompatible, biodegradable andnon-toxic cationic polymer that formspolyelectrolyte complexes with DNA [2]. Thep53 tumor suppressor gene, which is the focusof this paper, has been a major player innumerous gene therapy studies concerning thetreatment of cancer. The p53 tumor suppressorhas been implicated in more than 50% ofhuman cancers [3]. The p53 protein is DNAbindingand acts as a transcription factor tocontrol the expression of proteins involved inthe cell cycle [4]. In response to DNA damage,p53 accumulates in the cell nucleus, whichcauses cells to undergo cell cycle arrest andDNA repair or apoptosis. [5]. In this study, wehave determined the antiproliferative activityof wild-type (wt) p53 gene loadednanoparticles in a cancer cell line.
机译:安全,高效,有针对性地交付 治疗基因仍然是重要的 基因发展的瓶颈 治疗。新型生物相容性高分子基因 运营商已经检查了其潜力 在治疗各种遗传和获得性 疾病。内体释放效率低下 细胞质运输和核进入 质粒目前是限制蛋白表达的因素。 聚合物用于有效的基于质粒的应用 基因治疗[1]。因此,有几种不同的 设计了聚合基因载体 最近试图克服这些 问题。生物相容性低 免疫原性和最小的细胞毒性可以 使此类聚合物成为以下产品的良好替代品 病毒或脂质介导的转染。壳聚糖是 便宜,可生物相容,可生物降解且 形成的无毒阳离子聚合物 聚电解质与DNA的复合物[2]。这 p53抑癌基因,这是重点 在这篇论文中,一直是 关于基因的众多基因疗法研究 治疗癌症。 p53肿瘤抑制因子 已经牵涉到超过50%的 人类癌症[3]。 p53蛋白与DNA结合 并作为转录因子 控制参与其中的蛋白质的表达 细胞周期[4]。为了应对DNA损伤, p53积聚在细胞核中 使细胞经历细胞周期停滞和 DNA修复或凋亡。 [5]。在这项研究中,我们 确定了抗增殖活性 野生型(wt)p53基因的克隆 癌细胞系中的纳米颗粒。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号